{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-140017","form_type":"8-K","ticker":"ADPT","cik":"0001478320","company_name":"Adaptive Biotechnologies Corp","filed_at":"2025-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.417493+00:00","generated_at":"2026-05-19T10:32:48.237393+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Adaptive Biotechnologies shareholders elect Chad Robins and approve say-on-pay, auditor","bullets":["Chad Robins elected Class III director with 80.95% of votes cast; 12.8M broker non-votes.","Say-on-pay advisory proposal passed with 98.46% support; 1.23% against.","Ratification of Ernst & Young as 2025 auditor approved with 99.91% of votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-140017","json":"https://secwatch.observer/filing/0001193125-25-140017.json","markdown":"https://secwatch.observer/filing/0001193125-25-140017.md","text":"https://secwatch.observer/filing/0001193125-25-140017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1478320/000119312525140017/0001193125-25-140017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1478320/000119312525140017/d98087d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T10:32:48.237393+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}